The Influence of Multimorbidity on Clinical Progression of Dementia in a Population-Based Cohort
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Co-occurrence with other chronic diseases may influence the progression of dementia, especially in case of multiple chronic diseases. We aimed to verify whether multimorbidity influenced cognitive and daily functioning during nine years after dementia diagnosis compared with the influence in persons without dementia. METHODS: In the Kungsholmen Project, a population-based cohort study, we followed 310 persons with incident dementia longitudinally. We compared their trajectories with those of 679 persons without dementia. Progression was studied for cognition and activities of daily life (ADLs), measured by MMSE and Katz Index respectively. The effect of multimorbidity and its interaction with dementia status was studied using individual growth models. RESULTS: The mean (SD) follow-up time was 4.7 (2.3) years. As expected, dementia related to both the decline in cognitive and daily functioning. Irrespective of dementia status, persons with more diseases had significantly worse baseline daily functioning. In dementia patients having more diseases also related to a significantly faster decline in daily functioning. Due to the combination of lower functioning in ADLs at baseline and faster decline, dementia patients with multimorbidity were about one to two years ahead of the decline of dementia patients without any co-morbidity. In persons without dementia, no significant decline in ADLs over time was present, nor was multimorbidity related to the decline rate. Cognitive decline measured with MMSE remained unrelated to the number of diseases present at baseline. CONCLUSION: Multimorbidity was related to baseline daily function in both persons with and without dementia, and with accelerated decline in people with dementia but not in non-demented individuals. No relationship of multimorbidity with cognitive functioning was established. These findings imply a strong interconnection between physical and mental health, where the greatest disablement occurs when both somatic and mental disorders are present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Around 70–80% of people diagnosed with dementia in primary care have at least two other chronic illnesses.242, 243”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [243]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the general older population, people with dementia have increased rates of cerebrovascular disease,243, 244, 245, 246 stroke,247 Parkinson's disease,243, 245 diabetes,245, 247 skin ulcers, anxiety and depression,243, 245 pneumonia, incontinence, and electrolyte disturbance.245”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [243]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Current guidelines and literature inadequately addresses the complexity of managing MLTCiD with a tendency for a single-disease focus (i.e., only one of 13 NICE guidance documents acknowledged the impact of dementia on care management [20]) [21–24].”
From Do hospital-to-home transitions work for older adults with multiple long-term conditions including dementia? A realist review (2025) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence
Singer, J. D., & Willett, J. B. (2003) · doi:10.1093/acprof:oso/9780195152968.001.0001 · Cited by 10,647
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Aging with multimorbidity: A systematic review of the literature
Marengoni, A., Angleman, S., Melis, R., Mangialasche, F., Karp, A., Garmen, A., Meinow, B., & Fratiglioni, L. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.03.003 · Cited by 3,092 · cited 1×
“It is likely that multimorbidity may also affect daily functioning independently of the presence of dementia [16], and such an effect may also be present for cognitive functioning [17].”
BackgroundSelf-citationKatz, S. (1963) · JAMA · doi:10.1001/jama.1963.03060120024016 · Cited by 2,421 · cited 4×
“At all examinations in the Kungsholmen Project the data were collected following the same standardised protocols [18,19], with the exception of the measurement of disability using the Katz Index [20].”
MethodInfluentialMiller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990 · cited 1×
“The same may be true for measures that do not only capture the number but also the severity of the conditions present, such as the Cumulative Illness Rating Scale-Geriatrics [29].”
BackgroundThe Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,374
van den Akker, M., Buntinx, F., Metsemakers, J. F. M., Roos, S., & Knottnerus, J. A. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00306-5 · Cited by 1,027
Physical Activity, Diet, and Risk of Alzheimer Disease
Scarmeas, N. (2009) · JAMA · doi:10.1001/jama.2009.1144 · Cited by 916 · cited 2×
“An increasing body of evidence suggests an interrelatedness between physical and cognitive functioning [2– 4].”
BackgroundResultAge, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900 · cited 1×
“This is in line with the model outlined by Fotuhi et al and other researchers who suggested a dynamic polygon hypothesis [27,28].”
Result
Cited by
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedFabbri, E., Zoli, M., Gonzalez-Freire, M., Salive, M. E., Studenski, S. A., & Ferrucci, L. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.03.013 · Cited by 563
New horizons in multimorbidity in older adults
Yarnall, A. J., Sayer, A. A., Clegg, A., Rockwood, K., Parker, S., & Hindle, J. V. (2017) · Age and Ageing · doi:10.1093/ageing/afx150 · Cited by 361
“accelerate cognitive decline in those with underlying dementia [45].”
BackgroundMultimorbidity and Risk of Mild Cognitive Impairment
Vassilaki, M., Aakre, J. A., Cha, R. H., Kremers, W. K., St. Sauver, J. L., Mielke, M. M., Geda, Y. E., Machulda, M. M., Knopman, D. S., Petersen, R. C., et al. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13612 · Cited by 220
“In another study, multimorbidity was significantly associated with faster decline in daily functioning in individuals with dementia than in those without.(46) Effects of multimorbidity on functioning in individuals with dementia could result in greater disability than expected, possibly due to disturbances in normal c…”
BackgroundClague, F., Mercer, S. W., McLean, G., Reynish, E., & Guthrie, B. (2016) · Age and Ageing · doi:10.1093/ageing/afw176 · Cited by 195
“Research indicates that comorbidity may have a direct negative effect on the clinical manifestation of dementia [12, 25–27] including the potential to increase rate of cognitive decline and accelerate functional decline, up to 2 years before patients without comorbidity [27, 28].”
BackgroundBrowne, J., Edwards, D. A., Rhodes, K. M., Brimicombe, D. J., & Payne, R. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-012546 · Cited by 186
“Dementia can complicate the management of comorbid conditions(7) and comorbidities or their treatment can accelerate the progression of dementia.(8) 9 Identifying which groups have the greatest need for healthcare is essential to plan effective dementia care.”
BackgroundHusebo, B. S., Achterberg, W., & Flo, E. (2016) · CNS Drugs · doi:10.1007/s40263-016-0342-7 · Cited by 162
“Most of these people develop changes in their physical function caused by multimorbidity and increased vulnerability [9].”
BackgroundIncidence and Predictors of Multimorbidity in the Elderly: A Population-Based Longitudinal Study
Melis, R., Marengoni, A., Angleman, S., & Fratiglioni, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103120 · Cited by 115
Self-citationFabbri, E., An, Y., Zoli, M., Tanaka, T., Simonsick, E. M., Kitner‐Triolo, M. H., Studenski, S. A., Resnick, S. M., & Ferrucci, L. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14092 · Cited by 123
Comorbidity and progression of late onset Alzheimer’s disease: A systematic review
Haaksma, M. L., Vilela, L. R., Marengoni, A., Calderón-Larrañaga, A., Leoutsakos, J.-M. S., Olde Rikkert, M. G. M., & Melis, R. J. F. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177044 · Cited by 94
“(2013) also a cross-sectional association between baseline comorbidity burden and baseline functional status was found [33].”
Self-citationPolypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study
Kristensen, R. U., Nørgaard, A., Jensen‐Dahm, C., Gasse, C., Wimberley, T., & Waldemar, G. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170905 · Cited by 103
Griffith, L. E., Gruneir, A., Fisher, K., Panjwani, D., Gandhi, S., Sheng, L., Gafni, A., Patterson, C., Markle-Reid, M., & Ploeg, J. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0351-x · Cited by 88
“In people with dementia, comorbid conditions can accelerate cognitive [15] and functional [16] decline.”
BackgroundBayliss, E. A., Shetterly, S. M., Drace, M. L., Norton, J. D., Maiyani, M., Gleason, K. S., Sawyer, J. K., Weffald, L. A., Green, A. R., Reeve, E., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.0502 · Cited by 102
Dallora, A. L., Eivazzadeh, S., Mendes, E., Berglund, J., & Anderberg, P. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179804 · Cited by 82
Multimorbidity, dementia and health care in older people:a population-based cohort study
Tonelli, M., Wiebe, N., Straus, S., Fortin, M., Guthrie, B., James, M. T., Klarenbach, S. W., Tam-Tham, H., Lewanczuk, R., Manns, B. J., et al. (2017) · CMAJ Open · doi:10.9778/cmajo.20170052 · Cited by 68
Gerritsen, A. A. J., Bakker, C., Verhey, F. R. J., de Vugt, M. E., Melis, R. J. F., Koopmans, R. T. C. M., Oosterveld, S. M., Kessels, R. P. C., Rikkert, M. G. M. O., Hamel, R. E. G., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.11.011 · Cited by 72
Self-citationModifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease
Loeffler, D. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201182 · Cited by 76
Page, A. T., Potter, K., Clifford, R., McLachlan, A. J., & Etherton‐Beer, C. (2016) · Internal Medicine Journal · doi:10.1111/imj.13215 · Cited by 55
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment
Fabrizi, E., Ancidoni, A., Locuratolo, N., Piscopo, P., Gatta, F. D., Salemme, S., Pani, S. M., Marconi, D., Vignatelli, L., Sagliocca, L., et al. (2024) · Age and Ageing · doi:10.1093/ageing/afae250 · Cited by 58
Multimorbidity, cognitive function, and physical activity
Loprinzi, P. D. (2016) · AGE · doi:10.1007/s11357-016-9874-5 · Cited by 56
“Health”
BackgroundHaaksma, M. L., Rizzuto, D., Ramakers, I. H. G. B., Ptacek, S. G., Marengoni, A., van der Flier, W. M., Verhey, F. R. J., Rikkert, M. G. M. O., & Melis, R. J. F. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.06.020 · Cited by 49
Self-citationQuiñones, A. R., Kaye, J. A., Allore, H. G., Botoseneanu, A., & Thielke, S. M. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520960874 · Cited by 48
“Such work has consistently found that people with ADRD with multiple chronic conditions have a more rapid progression and worse outcomes than those with fewer conditions.(9) However, approaching multimorbidity as a homogeneous predictor, varying only in magnitude, overlooks key nuances related to specific combinations…”
BackgroundOosterveld, S. M., Kessels, R. P. C., Hamel, R. E. G., Ramakers, I. H. G. B., Aalten, P., Verhey, F. R. J., Sistermans, N., Smits, L. L., Pijnenburg, Y. A. L., van der Flier, W. M., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140138 · Cited by 47
“Other studies have already shown that (i)ADL functioning is an independent predictor of survival in AD [42], even after controlling for cognitive performance [43, 44].”
Self-citationConceptualising comorbidity and multimorbidity in dementia: A scoping review and syndemic framework
Dunn, R., Clayton, E., Wolverson, E., & Hilton, A. (2022) · Journal of Multimorbidity and Comorbidity · doi:10.1177/26335565221128432 · Cited by 41
Soysal, P., Perera, G., Işık, A. T., Onder, G., Petrović, M., Cherubini, A., Maggi, S., Shetty, H., Molokhia, M., Smith, L., et al. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.02.019 · Cited by 43
Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes
Haaksma, M. L., Calderón-Larrañaga, A., Olde Rikkert, M. G. M., Melis, R. J. F., & Leoutsakos, J. S. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4893 · Cited by 39
Self-citationJeon, Y.-H., Krein, L., Simpson, J. M., Szanton, S. L., Clemson, L. M., Naismith, S. L., Low, L., Mowszowski, L., Gonski, P. N., Norman, R., et al. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1642298 · Cited by 40
Jeon, Y., Simpson, J. M., Low, L., Woods, B. T., Norman, R., Mowszowski, L., Clemson, L. M., Naismith, S. L., Brodaty, H., Hilmer, S. N., et al. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1216-x · Cited by 45
Bendayan, R., Zhu, Y., Federman, A. D., & Dobson, R. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab009 · Cited by 37
“Our results differed from those reported by Melis et al. (7) who found a faster decline in cognitive performance over 5 years but it should be noted that their sample consisted only of individuals with dementia while our study focused on dementia free population and aimed to draw conclusions from…”
InfluentialMedical Comorbidities of Dementia: Links to Caregivers' Emotional Difficulties and Gains
Polenick, C. A., Min, L., & Kales, H. C. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16244 · Cited by 33
Trevisan, C., Limongi, F., Siviero, P., Noale, M., Cignarella, A., Manzato, E., Sergi, G., & Maggi, S. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01420-2 · Cited by 42
“It is well established that polypharmacy is a proxy indicator of an individual’s clinical complexity and multi-morbidity, both well-known risk factors for dementia [4, 5], but multidrug regimens per se may also independently affect cognitive status by several pathways.”
BackgroundParker, K. J., Hickman, L. D., Phillips, J. L., & Ferguson, C. (2020) · Contemporary Nurse · doi:10.1080/10376178.2020.1812416 · Cited by 27
Derby, C. A. (2020) · Current Epidemiology Reports · doi:10.1007/s40471-020-00231-8 · Cited by 30
Slachevsky, A., Pedro Zitko, M., Martínez‐Pernía, D., Forno, G., Court, F. A., Lillo, P., Villagra, R., Duran-Aniotz, C. A., Parrao, T., Assar, R., et al. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01866-4 · Cited by 31
How to manage comorbidities in people with dementia: A scoping review
Ma, D., Wang, Y., Zhao, Y., Meng, X., Su, J., Zhi, S., Song, D., Gao, S., Sun, J., & Sun, J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101937 · Cited by 25
Kao, S., Wang, J., Chen, S., Li, Y., Ya-lin, Y., & Lo, R. Y. (2021) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000514651 · Cited by 28
Medication use to manage comorbidities for people with dementia: a systematic review
Page, A. T., Etherton‐Beer, C., Seubert, L., Clark, V., Hill, X., King, S., & Clifford, R. M. (2018) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1403 · Cited by 23
Eshetie, T. C., Nguyen, T. A., Gillam, M., & Ellett, L. M. K. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2341 · Cited by 24
Multifactorial 10-Year Prior Diagnosis Prediction Model of Dementia
Dallora, A. L., Minku, L. L., Mendes, E., Rennemark, M., Anderberg, P., & Berglund, J. S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186674 · Cited by 22
“Dementia refers to a set of complex neurodegenerative disorders that are characterized by progressive cognitive deterioration and increasing disabilities that affect the individual’s independence, social and professional functioning [1,2].”
BackgroundLiao, W., Hamel, R. E. G., Rikkert, M. G. M. O., Oosterveld, S. M., Aalten, P., Verhey, F. R. J., Scheltens, P., Sistermans, N., Pijnenburg, Y. A. L., van der Flier, W. M., et al. (2016) · BMC Neurology · doi:10.1186/s12883-016-0750-9 · Cited by 24
“[28] or [6]) and clinical samples of MCI and dementia (e.”
BackgroundSelf-citationBratzke, L. C., Carlson, B., Moon, C., Brown, R., Koscik, R. L., & Johnson, S. C. (2018) · Applied Nursing Research · doi:10.1016/j.apnr.2018.06.004 · Cited by 21
“48) [27], A priori designs with attention to MCC are needed.”
BackgroundMartyr, A., Gamble, L. D., Nelis, S. M., Collins, R., Alexander, C. M., Morris, R. G., Quinn, C., Pentecost, C., Rusted, J. M., Victor, C. R., et al. (2022) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000524607 · Cited by 18
Tanaka, H., Nagata, Y., Ishimaru, D., Ogawa, Y., Fukuhara, K., & Nishikawa, T. (2019) · Psychogeriatrics · doi:10.1111/psyg.12502 · Cited by 18
Jeon, Y., Simpson, J. M., Fethney, J., Krein, L., Shin, M., Low, L., Woods, B. T., Mowszowski, L., Hilmer, S. N., Naismith, S. L., et al. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2024-334514 · Cited by 17
Dallora, A. L., Eivazzadeh, S., Mendes, E., Berglund, J. S., & Anderberg, P. (2016) · Procedia Computer Science · doi:10.1016/j.procs.2016.09.185 · Cited by 17
Lee, Y., Cho, Y., & Oh, H. (2020) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2020.1790492 · Cited by 17
“, attention, verbal memory, executive function) to measure cognitive function (Caracciolo et al., 2013; Fabbri et al., 2016; Melis et al., 2013) or combined”
BackgroundResultInfluentialPimouguet, C., Goff, M. L., Rizzuto, D., Berr, C., Leffondré, K., Pérès, K., Dartigues, J., & Helmer, C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150574 · Cited by 16
“functional decline notably in basic ADL for people with dementia even at the disease onset [28].”
Self-citationDrugs for Dementia and Excess of Hospitalization: A Longitudinal French Study
François, M., Sicsic, J., & Pelletier‐Fleury, N. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170371 · Cited by 15
Page, A. T., Clifford, R. M., Potter, K., Seubert, L., McLachlan, A. J., Hill, X., King, S., Clark, V., Ryan, C. A., Parekh, N., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017906 · Cited by 12
“4 Effective management of multiple comorbid conditions is critical, as suboptimal management can exacerbate functional decline.(5) 6 Although older people frequently use medications to manage symptoms and to prevent disease progression and disabling events,(7) 8 there is a limited understanding of appropriate pharmaco…”
BackgroundJang, A. R., & Yoon, J. Y. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13783 · Cited by 14
Seibert, K., Stiefler, S., Domhoff, D., Wolf‐Ostermann, K., & Peschke, D. (2022) · BMC Geriatrics · doi:10.1186/s12877-021-02731-8 · Cited by 14
Lawson, L., Cooper, M., Tolley, C., Hand, A., & Nazar, H. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06123-0 · Cited by 10
Wang, L., Lou, Y., Jiang, Q., Wang, H., Huang, S., Xie, Y., Wang, F., & Cao, S. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119958 · Cited by 12
Xiong, F., Wang, Y., Zhu, J., Li, S., Guan, Q., & Jing, Z. (2023) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6021 · Cited by 11
Temedda, M. N., Garnier‐Crussard, A., Mouchoux, C., & Dauphinot, V. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.51 · Cited by 10
“Fax: +33 (0) 472432054, E-mail address: virginie.dauphinot@chu-lyon.fr these one did not use a comorbidity index (23), and another used the Clinical Dementia Rating – sum of boxes that encompassed more than just ADL precluding conclusions as to the association between comorbidities and functional…”
Liu, Y., & Jiang, D. (2022) · Journal of Aging and Health · doi:10.1177/08982643221080287 · Cited by 10
“…function found that adults with multimorbidity had a higher risk of SCD-related, or more broadly, cognitive-related functional impairment (Caracciolo et al., 2013; Jindai et al., 2016; Melis et al., 2013; Taylor et al., 2020), but, the synergistic effect of chronic diseases was not considered.”
BackgroundCare Need Combinations for Dementia Patients with Multiple Chronic Diseases
Jhang, K.-M., Wang, W., Cheng, Y.-C., Tung, Y., Yen, S., & Wu, H. (2023) · Psychology Research and Behavior Management · doi:10.2147/prbm.s388394 · Cited by 10
“Care (2): Disease knowledge education Care (16): Hypertension care Feeding: Independent Hypnotics: No use 10.”
BackgroundInfluentialvan Dam, P. H., Achterberg, W. P., Gussekloo, J., Husebo, B. S., & Caljouw, M. A. A. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0974-1 · Cited by 10
Multimorbidity and associated outcomes among older adult inpatients with neurological disorders
Bacellar, A., Assis, T., Pedreira, B. B., CÔRTES, L., SANTANA, S., & Nascimento, O. J. M. (2021) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2020-0091 · Cited by 10
Hajek, A., Kretzler, B., Riedel-Heller, S. G., & König, H. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2022.104804 · Cited by 10
Caregivers’ Burden on Patients with Dementia Having Multiple Chronic Diseases
Jhang, K.-M., Liao, G.-C., Wang, W., Tung, Y., Yen, S., & Wu, H. (2024) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s454796 · Cited by 8
“12 13–15 Most chronic diseases required some degree of self-management, and dementia could undermine this capacity.”
BackgroundProfiling the hospital-dependent patient in a large academic hospital: Observational study
Ticinesi, A., Nouvenne, A., Prati, B., Lauretani, F., Morelli, I., Tana, C., Fabi, M., & Meschi, T. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.02.013 · Cited by 8
Cognitive impairment as a barrier to utilizing preventive health services among older adults
Kang, S., & Xiang, X. (2021) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2021.104613 · Cited by 7
[Solitary plasmacytoma: a clinicopathologic and immunophenotypic analysis of 43 cases].
Yang, F., Liu, W., Jiang, L., Li, F., Liao, D., & Li, G. (2006) · PubMed · Cited by 8
Chronic disease management and dementia: a qualitative study of knowledge and needs of staff
Baird, C., Woolford, M. H., Young, C., Winbolt, M., & Ibrahim, J. (2019) · Australian Journal of Primary Health · doi:10.1071/py18197 · Cited by 6
Prevalence of multimorbidity and its impact on survival in people with motor neuron disease
Glasmacher, S. A., Kearns, P. K. A., Larraz, J., Stirland, L., Mehta, A. R., Newton, J. L., Weir, C. J., Chandran, S., & Pal, S. (2021) · European Journal of Neurology · doi:10.1111/ene.14940 · Cited by 6
Hovsepian, V. E., Sadak, T. I., Schlak, A. E., Liu, J., & Poghosyan, L. (2023) · Journal of Applied Gerontology · doi:10.1177/07334648231155444 · Cited by 6
“This is notable because PLWD with comorbidities have increased rates of polypharmacy, hospitalizations, and cognitive and functional decline (Clague et al., 2017; Lin et al., 2013; Melis et al., 2013).”
BackgroundComorbidities predict institutionalization and mortality in biomarker-confirmed alzheimer’s disease
Xia, X., Clark, A., Brogaard, N. J., Mourer, A., Areovimata, A., Eriksdotter, M., Zetterberg, H., Kern, S., Skillbäck, T. B., & Jönsson, L. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01807-6 · Cited by 4
“Comorbidities in dementia have been associated with faster functional decline, which can explain the elevated risks of institutionalization in people with biomarker-confirmed AD dementia who have comorbidities [53, 54].”
Edwards, S., Evans, M., Ritchie, C. W., Hahn‐Pedersen, J. H., Chan, M. S., Bray, B., Clark, A., Wichmann, C. A., & Trépel, D. (2025) · Aging and Health Research · doi:10.1016/j.ahr.2025.100234 · Cited by 5
小林, 啓., & Arai, H. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.03.002 · Cited by 4
Facteurs de risque de la maladie d’Alzheimer et des maladies apparentées : approche parcours de vie
Singh‐Manoux, A., & Sabia, S. (2020) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2020.01.015 · Cited by 5
Pytka, D., & Czarkowska‐Pączek, B. (2020) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000509543 · Cited by 3
A comparison of two approaches for modeling dementia progression in a changing patient context
Wubben, N., Haaksma, M. L., Ramakers, I. H. G. B., van der Flier, W. M., Verhey, F. R. J., Rikkert, M. G. M. O., & Melis, R. J. F. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5706 · Cited by 3
“These results are in line with a Swedish population‐based study in incident dementia cases, which found no association between baseline comorbidity and cognitive decline either.(13) Neither did another longitudinal study in incident dementia cases in the United States.”
BackgroundResultInfluentialSelf-citationFalkenreck, J. M., Roheger, M., Weigert, H., Friese, A., Jahr, P., Becker, I., Nelles, G., Kalbe, E., & Polidori, M. C. (2020) · Geriatric Care · doi:10.4081/gc.2020.9328 · Cited by 3
Fogel, A., Walsh, C., Fletcher‐Lloyd, N., Malhotra, P., Ryten, M., Nilforooshan, R., & Barnaghi, P. M. (2026) · Communications Medicine · doi:10.1038/s43856-026-01432-w · Cited by 2
Accelerating real‐world prediction and research in Alzheimer's: The M3AD study
Desvarieux, M., Rundek, T., Ahsan, H., Narvaez, J., Diaz, F., Malinsky, D., Ruiz, L. M., Topaz, M., Falconer, T., Natarajan, K., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71174 · Cited by 2
Prediction of Autonomy Loss in Alzheimer’s Disease
Nicolas, A., Ducher, M., Bourguignon, L., Dauphinot, V., & Krolak‐Salmon, P. (2021) · Forecasting · doi:10.3390/forecast4010002 · Cited by 2
Khalid, S., Innes, K. E., Umer, A., Lilly, C. L., Gross, D., & Sambamoorthi, U. (2022) · Research Square · doi:10.1101/2022.08.02.22278338 · Cited by 3
Investigation of the Effects of Polypharmacy on Cognitive Functions: Cohort Study
Bektay, M. Y., Gökçe, M., Selvitop, R., Bolat, E., & Yıldız, G. B. (2021) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.55.1s.64 · Cited by 1
Frailty, Dementia and Multi‐Morbidity
Russell, S. (2024) · Wiley eBooks · doi:10.1002/9781119784395.ch16 · Cited by 1
Dementia and use of drugs : economic modelling and population-based studies
Sköldunger, A. (2015) · Figshare · Cited by 6
The course of mild cognitive impairment and the role of comorbidity
Hamel, R. E. G. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20150703rh · Cited by 2
Powers, R. E., & Herrington, H. (2015) · Springer eBooks · doi:10.1007/978-3-319-18377-0_16
Psychometric Extension of the Memory for Names Test
Foil, H. C. (2016) · Louisiana State University · doi:10.31390/gradschool_theses.1011
“Multimorbidity is also associated with an increased likelihood of hospitalization and subsequent mortality in persons with dementia (Doraiswamy et al., 2002; Melis et al., 2013).”
BackgroundZolotovskaya, I. A., & Davydkin, I. L. (2017) · Russian Journal of Preventive Medicine · doi:10.17116/profmed201720340-46
Cordier, M. (2018) · theses.fr (ABES) · doi:10.70675/8a7a4afcz0f25z4e00z8f41z7cd8848aa51b · Cited by 1
Developing a complex intervention to coordinate care for people with dementia
Backhouse, A. (2017) · Figshare
Thalén, L. (2019) · Figshare · Cited by 1
Khalid, S. (2020) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7813
Fabbri, E., Boccardi, V., Guazzarini, A. G., Murasecco, I., Melis, F., Bastiani, P., Muratori, P., Ruggiero, C., & Mecocci, P. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03133-1
Seibert, K., Stiefler, S., Domhoff, D., Wolf‐Ostermann, K., & Peschke, D. (2022) · Figshare · doi:10.6084/m9.figshare.18462032
Slachevsky, A., Pedro Zitko, M., Martínez‐Pernía, D., Forno, G., Court, F. A., Lillo, P., Villagra, R., Duran-Aniotz, C. A., Parrao, T., Assar, R., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13290634
Dementia: risk factors for disease progression and mortality
Sequeira, R. R. L. R. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/vsea-4f69
Seibert, K., Stiefler, S., Domhoff, D., Wolf‐Ostermann, K., & Peschke, D. (2022) · Figshare · doi:10.6084/m9.figshare.18462029
Seibert, K., Stiefler, S., Domhoff, D., Wolf‐Ostermann, K., & Peschke, D. (2022) · Figshare · doi:10.6084/m9.figshare.18462026
The epidemiology of neurocognitive disorders in Hungary
Váraljai, C., Horvath, A. A., & Kamondi, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-44201-4
Multimorbidity research in dementia: it’s time to shift to a person-centred approach
Swain, S., Kantilal, K., Suryadevara, V., & Stirland, L. (2026) · Frontiers in Dementia · doi:10.3389/frdem.2026.1791795
“…between dementia and multimorbidity is associated with accelerated cognitive and functional decline, increased healthcare utilization, impaired quality of life, 10.3389/frdem.2026.1791795 Frontiers in Dementia 02 frontiersin.org and higher mortality risk (Browne et al., 2017; Melis et al., 2013).”
InfluentialDening, K. H. (2014) · UCL Discovery (University College London) · Cited by 1
Metadata
- Authors
- Melis, R. J. F., Marengoni, A., Rizzuto, D., Teerenstra, S., Kivipelto, M., Angleman, S. B., & Fratiglioni, L.
- Affiliations
- Radboud University Medical Center (NL)
- University of Brescia (IT)
- Stockholm University (SE)
- Corresponding author
- Melis, René J. F.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-30
- Volume
- 8
- Issue
- 12
- Pages
- e84014
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3875493
- OpenAlex
- W2079282691
- Cited by
- 96
- References
- 33
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 11 · 2021: 8 · 2020: 12 · 2019: 11 · 2018: 8 · 2017: 8 · 2016: 10 · 2015: 6 · 2014: 3
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (825.08.008)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- multimorbidity, dementia progression, cognitive decline, activities of daily living, functional decline, chronic comorbidities, Kungsholmen Project, individual growth models
- MeSH terms
- Activities of Daily Living, Aged, Aged, 80 and over, Cognition, Dementia, Female, Follow-Up Studies, Humans, Male, Cohort Studies, Comorbidity, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.